Company Research Report: Perrigo Company plc

Company Overview

Name: Perrigo Company plc

Mission: To make lives better by bringing quality, affordable self-care products that consumers trust everywhere they are sold.

Founded: 1887

Founder: Luther Perrigo

Headquarters: Allegan, Michigan, United States

Key People:

• Patrick Lockwood-Taylor: President & Chief Executive Officer

• Charles Atkinson: Executive Vice President, General Counsel and Secretary

• David Ball: Executive Vice President, Chief Brand and Digital Officer

• Eduardo Bezerra: Executive Vice President and Chief Financial Officer

• Alison Ives: Executive Vice President and Chief Scientific Officer

• Ron Janish: Executive Vice President of Global Operations and Supply Chain

• Roberto Khoury: Executive Vice President & President, Consumer Self-Care International

• Catherine "Triona" Schmelter: Executive Vice President & President, Consumer Self-Care Americas

• Rob Willis: Executive Vice President & Chief Human Resources Officer

Employees: No specific number of employees provided.

Revenue: No revenue information available.

Known For: Perrigo Company is a leading global provider of over-the-counter (OTC) health and wellness solutions, specializing in empowering consumers to prevent or treat conditions they can self-manage.

Products

Product Categories:

1. Infant Formula

• Advantage® Non-GMO Infant Formula: Ingredients not genetically engineered. Comparable to: Similac PRO-ADVANCE®.

2. Pain Relief

• Acetaminophen: Comparable to: Tylenol® Extra Strength Caplets active ingredient.

• Ibuprofen Tablets 200 mg: Comparable to: Advil® active ingredient.

3. Allergy and Cold Remedies

• Allergy Relief - Loratadine Tablets 10 mg: Comparable to: Claritin® Tablets active ingredient.

• Bronchenolo

• Coldrex Range Products

• Famotidine Tablets 20 mg: Comparable to Original Strength Pepcid AC® active ingredient.

• Omeprazole Delayed Release Tablets 20 mg: Comparable to: Prilosec OTC®.

4. Hair and Skin Care

• Minoxidil Topical Solution USP: 5% Hair Regrowth Treatment for men. Comparable to: Men’s Rogaine® Extra Strength Active Ingredient.

• Tolnaftate 1% Liquid Spray: Comparable to: Tinactin® Active Ingredient.

5. Nicotine and Health Aids

• Nicotine Polacrilex Lozenge 4 mg (Cherry Ice): Comparable to: Nicorette® mini Lozenge active ingredient.

• Solpadeine Headache

6. Personal Care

• Personal Lubricant Jelly: Comparable to: KY® Jelly.

7. Oral Self-Care

• Teeth Whitening Products: Comparable to: Crest® 3D White™ Whitestrips.

• Plackers® Brand: Dental flossers, night guards, and interdental brushes.

• REMBRANDT® Brand: Teeth whitening toothpastes and strips.

Recent Developments

• Partnerships:

• On September 26, 2024, Perrigo announced a partnership with Good Start® and Dr. Browns®, launching an infant formula portfolio.

• Product Recalls:

• On August 8, 2024, Perrigo issued a voluntary recall of one batch of Premium Infant Formula with Iron Milk-Based Powder due to elevated levels of Vitamin D.

• Media Engagements and Initiatives:

• Perrigo has partnered with WNBA star Napheesa Collier for candid conversations on women's health with Team Opill, as of October 16, 2024.

• Commences a new headquarters project on "Medical Mile" in Grand Rapids, Michigan.

• Charitable Efforts:

• Perrigo's charitable initiatives include donating over $30.6 million in cash and $19.3 million in products over the past decade.

• New Product Launch:

• Launched "Coldrex Plus cough"—a new addition to the Coldrex range available in hot drinks format.

Note: Many other strategic details, including specific fiscal figures, are not available based on the provided data.

This report attempts to comprehensively analyze the available information about Perrigo Company plc as provided, adhering strictly to the details disclosed in the data.